Belgian biotech eTheRNA Immunotherapies NV, that uses messenger RNA to treat cancers, has hired Ulrich Platte as chief financial officer. Mr Platte is a graduate of the University of Chicago Business School, US and has extensive knowledge of finance as well as large research and development operations.
eTheRNA Immunotherapies announced the appointment on 29 May 2019
Copyright 2019 Evernow Publishing Ltd